FCRL5 and plasma cell myeloma: Additionally, levels of soluble FcRH5 are known to be elevated in the blood of multiple myeloma patients6, and this shed form of FcRH5 may have resulted in decreased binding of DFRF4539A to membrane-bound FcRH5.